Group 1 - The core point of the news is the establishment of Xiamen Taisengyuan Biopharmaceutical Co., Ltd., with a registered capital of 3.1 million RMB, fully owned by Xiamen Taisengyuan Cell Technology Research Institute Co., Ltd. [1][2] - The legal representative of the company is Liu Xiang, and it is classified under the scientific research and technical service industry, specifically in research and experimental development [2]. - The company's business scope includes drug production, wholesale and retail of drugs, cell technology research and application, human stem cell technology development, and various other technical services and health consulting services [1][2]. Group 2 - The company is located at No. 2036, Wengjiao West Road, Haicang District, Xiamen, in the Xiamen Biopharmaceutical Industry Park [2]. - The company is a limited liability company with a natural person investment or control, and its business term is set until February 12, 2026, with no fixed expiration [2].
厦门泰生源生物药业有限公司成立，注册资本310万人民币
Sou Hu Cai Jing·2026-02-12 17:48